Novel Sirolimus Formulation Approved for Rare Soft Tissue Sarcoma Novel Sirolimus Formulation Approved for Rare Soft Tissue Sarcoma

For the first time, a product has been approved specifically for use in malignant perivascular epithelioid cell tumors, a type of soft-tissue sarcoma.FDA Approvals
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Alert Source Type: news